FDA approves risankizumab as a treatment for plaque psoriasis FDA, 판상 건선 치료제로 리산키주맙 승인
FDA, 판상 건선 치료제로 리산키주맙 승인 FDA approves risankizumab as a treatment for plaque psoriasis Reuters (4/23, Babu, Nair) reports that yesterday, “AbbVie Inc said that the FDA has approved its Skyrizi [risankizumab] drug as a treatment for plaque psoriasis.” According … Continued